Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 316.77 | 1445 / 1445 | 100% | 18.59 | 183 / 183 |
| lung | 100% | 340.68 | 578 / 578 | 100% | 22.20 | 1155 / 1155 |
| ovary | 100% | 322.70 | 180 / 180 | 100% | 24.72 | 430 / 430 |
| stomach | 100% | 268.43 | 359 / 359 | 100% | 21.12 | 286 / 286 |
| brain | 100% | 227.74 | 2639 / 2642 | 100% | 21.60 | 705 / 705 |
| prostate | 100% | 353.14 | 245 / 245 | 100% | 24.07 | 501 / 502 |
| breast | 100% | 395.40 | 459 / 459 | 100% | 23.01 | 1115 / 1118 |
| pancreas | 100% | 160.57 | 327 / 328 | 100% | 21.51 | 178 / 178 |
| uterus | 100% | 321.11 | 170 / 170 | 100% | 25.65 | 457 / 459 |
| thymus | 100% | 363.32 | 652 / 653 | 100% | 25.47 | 603 / 605 |
| intestine | 100% | 355.98 | 966 / 966 | 99% | 22.58 | 524 / 527 |
| liver | 100% | 235.12 | 226 / 226 | 99% | 16.57 | 403 / 406 |
| bladder | 100% | 360.95 | 21 / 21 | 99% | 22.03 | 498 / 504 |
| skin | 100% | 359.90 | 1809 / 1809 | 99% | 16.94 | 466 / 472 |
| kidney | 100% | 364.24 | 89 / 89 | 98% | 16.16 | 882 / 901 |
| adrenal gland | 100% | 302.23 | 258 / 258 | 94% | 17.15 | 217 / 230 |
| adipose | 100% | 384.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 42.96 | 29 / 29 |
| spleen | 100% | 380.15 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 22.86 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.62 | 1 / 1 |
| blood vessel | 100% | 325.74 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 293.78 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 298.04 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 305.98 | 918 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 17.27 | 79 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
| GO_0070936 | Biological process | protein K48-linked ubiquitination |
| GO_0070979 | Biological process | protein K11-linked ubiquitination |
| GO_0051301 | Biological process | cell division |
| GO_0051445 | Biological process | regulation of meiotic cell cycle |
| GO_0007346 | Biological process | regulation of mitotic cell cycle |
| GO_0005680 | Cellular component | anaphase-promoting complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CDC26 |
| Protein name | Anaphase-promoting complex subunit CDC26 (Anaphase-promoting complex subunit 12) (APC12) (Cell division cycle protein 26 homolog) |
| Synonyms | ANAPC12 C9orf17 |
| Description | FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. May recruit the E2 ubiquitin-conjugating enzymes to the complex. . |
| Accessions | ENST00000374206.4 Q8NHZ8 |